317 related articles for article (PubMed ID: 28093659)
1. Clinical and molecular relevance of mutant-allele tumor heterogeneity in breast cancer.
Ma D; Jiang YZ; Liu XY; Liu YR; Shao ZM
Breast Cancer Res Treat; 2017 Feb; 162(1):39-48. PubMed ID: 28093659
[TBL] [Abstract][Full Text] [Related]
2. Intra-tumoral heterogeneity and immune responses predicts prognosis of gastric cancer.
Feng W; Wang Y; Chen S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):24333-24344. PubMed ID: 33259333
[TBL] [Abstract][Full Text] [Related]
3. Intra-tumor genetic heterogeneity and mortality in head and neck cancer: analysis of data from the Cancer Genome Atlas.
Mroz EA; Tward AD; Hammon RJ; Ren Y; Rocco JW
PLoS Med; 2015 Feb; 12(2):e1001786. PubMed ID: 25668320
[TBL] [Abstract][Full Text] [Related]
4. Gender-related prognostic value and genomic pattern of intra-tumor heterogeneity in colorectal cancer.
Zhang J; Yan S; Liu X; Gan L; Wu Z; Gong Y; Huang M; Zhang X; Guo W
Carcinogenesis; 2017 Aug; 38(8):837-846. PubMed ID: 28531253
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of mutant-allele tumor heterogeneity and lung adenocarcinoma.
Mao H
Ann Transl Med; 2019 Sep; 7(18):432. PubMed ID: 31700868
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Genes in Gastric Cancer with High Heterogeneity Based on Weighted Gene Co-Expression Network.
Dong Z; Pei S; Zhao Y; Guo S; Wang Y
Crit Rev Eukaryot Gene Expr; 2020; 30(2):101-109. PubMed ID: 32558489
[TBL] [Abstract][Full Text] [Related]
7. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
Elife; 2020 May; 9():. PubMed ID: 32401198
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
[TBL] [Abstract][Full Text] [Related]
9. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
10. Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis.
Han Y; Liu X; Ye H; Tian Y; Ji Z
World J Surg Oncol; 2020 Nov; 18(1):310. PubMed ID: 33243261
[TBL] [Abstract][Full Text] [Related]
11. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
[TBL] [Abstract][Full Text] [Related]
12. Genomic pattern of intratumor heterogeneity predicts the risk of progression in early stage diffuse large B-cell lymphoma.
Wang Y; Feng W; Liu P
Carcinogenesis; 2019 Nov; 40(11):1427-1434. PubMed ID: 31220210
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma.
Hou Y; Li T; Gan W; Lv S; Zeng Z; Yan Z; Wang W; Yang M
Ann Transl Med; 2020 Mar; 8(6):339. PubMed ID: 32355783
[TBL] [Abstract][Full Text] [Related]
14. Multi-region and single-cell sequencing reveal variable genomic heterogeneity in rectal cancer.
Liu M; Liu Y; Di J; Su Z; Yang H; Jiang B; Wang Z; Zhuang M; Bai F; Su X
BMC Cancer; 2017 Nov; 17(1):787. PubMed ID: 29169336
[TBL] [Abstract][Full Text] [Related]
15. Mutant-Allele Tumor Heterogeneity, a Favorable Biomarker to Assess Intra-Tumor Heterogeneity, in Advanced Lung Adenocarcinoma.
Wu X; Song P; Guo L; Ying J; Li W
Front Oncol; 2022; 12():888951. PubMed ID: 35847947
[TBL] [Abstract][Full Text] [Related]
16. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma.
Mroz EA; Rocco JW
Oral Oncol; 2013 Mar; 49(3):211-5. PubMed ID: 23079694
[TBL] [Abstract][Full Text] [Related]
17. Cell-free DNA as a molecular tool for monitoring disease progression and response to therapy in breast cancer patients.
Liang DH; Ensor JE; Liu ZB; Patel A; Patel TA; Chang JC; Rodriguez AA
Breast Cancer Res Treat; 2016 Jan; 155(1):139-49. PubMed ID: 26667234
[TBL] [Abstract][Full Text] [Related]
18. ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast.
Ping Z; Siegal GP; Harada S; Eltoum IE; Youssef M; Shen T; He J; Huang Y; Chen D; Li Y; Bland KI; Chang HR; Shen D
Oncotarget; 2016 Dec; 7(49):80655-80663. PubMed ID: 27811364
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of intratumoural heterogeneity of somatic copy number alterations in diffuse glioma reveals clonality-dependent prognostic patterns.
Luo S; Zhang Y; Jia Y; Zhang X
Neuropathol Appl Neurobiol; 2022 Oct; 48(6):e12831. PubMed ID: 35767937
[TBL] [Abstract][Full Text] [Related]
20. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
